Organization (Academic)
Pusan National University
ClinicalTrials.gov lists Pusan National University as lead sponsor of 97 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Pusan National University, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Pusan National University and 1 company grouped under it: 97 lead-sponsored trials (17 its own, 80 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Companies grouped under this page (1)
| Company | Lead trials | Legal entities |
|---|---|---|
| Pusan National University Hospital | 80 | 1 |
Disease areas (171)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Lung Neoplasms | 12 |
| Diabetes Mellitus | 11 |
| Lymphoma | 9 |
| Lymphoma, Non-Hodgkin | 8 |
| Obesity | 8 |
Showing 5 of 171 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 6 |
| 2013 | 2 |
| 2011 | 3 |
| 2010 | 3 |
Recruitment duration, a model prediction: none of the 17 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Journals published in (196)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The New England journal of medicine | 12 |
| Blood | 9 |
| Gastrointestinal endoscopy | 8 |
| Ophthalmology | 8 |
| PloS one | 6 |
Showing 5 of 196 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 3 | 0 | 2019-07-09 |
Organization relationships (62)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Yonsei University | Co sponsors trial with | 13 |
| Korea University | Co sponsors trial with | 11 |
| Asan Foundation | Co sponsors trial with | 11 |
| Samsung (South Korea) | Co sponsors trial with | 10 |
| Keimyung University Dongsan Medical Center | Co sponsors trial with | 9 |
Showing 5 of 62 relationships.
Latest dated events (172)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-10-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-06-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 172 events.
Biomarker capability evidence (7)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| SIRPA | Trial sponsor | Named in trial inclusion criteria |
| VEGFA | Trial collaborator | Named in trial exclusion criteria |
| ADIPOQ | Trial sponsor | Mentioned in trial text |
| EDN1 | Trial sponsor | Mentioned in trial text |
| LEP | Trial sponsor | Mentioned in trial text |
Showing 5 of 7 evidence rows.
Biomarkers this organization publishes on (357)
Shown in this order: most publications first.
Showing 5 of 357 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.